Latest news bulletin | September 6th, 2025 – Midday
More about this topic
Vaccine doubts could delay EU's inoculation target by several months
Projections show issues with the AstraZeneca and Johnson & Johnson vaccine rollouts could seriously dent the EU’s goal of vaccinating 70% of adults against COVID-19 by the end of summer.
COVID mass vaccination centre in Nice closes as just 58 people turn up
More than 4,000 doses of the AstraZeneca jab were available at the centre this weekend but it closed after a few hours due to low turnout.
'Highly probable' the EU will ditch its AstraZeneca contract: minister
France's industry minister said on Friday that while a final decision was yet to be made, it was "highly probable" the EU wouldn't renew its contract for the Oxford/AstraZeneca COVID vaccine.
EU countries express interest in Denmark's AstraZeneca vaccines
The World Health Organization said that Denmark was considering sharing unused vaccine doses with poorer countries.
ADVERTISEMENT
Norway's public health institute recommends axing AstraZeneca jab
It comes a day after Denmark became the first country in Europe to abandon the jab over links with very rare blood clots.
Denmark becomes first in Europe to abandon AstraZeneca vaccine
The decision was taken due to the vaccine's link with very rare cases of blood clots, the country's health agency said.
Mix and match COVID vaccine study expanded to include Moderna, Novavax
The aim of the study is to assess how well people's immune systems respond when their second "boost" dose is a different type of vaccine to their first "prime" dose.
EU received only half of AstraZeneca doses it was meant to this week
AstraZeneca's deliveries to the European Union have been beset by delays.
Europe's week: AstraZeneca jab troubles and Turkey's diplomacy mistake
The European Medicines Agency said the Oxford/AstraZeneca vaccine could potentially cause rare blood clots and Commission President von der Leyen got sidelined in Ankara. Here's a look at two key stories making the news in Brussels this week.
AstraZeneca: France says under 55s to receive different second dose
France's health authority has recommended that adults under 55 who received a first dose of AstraZeneca's COVID-19 vaccine should receive a different vaccine for their second dose.
Australia buys 20 million more Pfizer/BioNTech vaccines for COVID-19
The announcement comes hours after Australia said it would stop using the AstraZeneca jab on those under 50 years old.
Countries change tack on AstraZeneca vaccine despite EU call for unity
Countries are changing their recommendations for who should receive the AstraZeneca coronavirus jab after the EMA confirmed a "possible link" between the vaccine and a rare form of blood clot.
Possible link between AstraZeneca jab and rare blood clots, says EMA
The EU medicines regulator said there was a "possible link" between the AstraZeneca jab and "very rare" blood clots. They maintained that the benefits of the vaccine outweigh the risks.
Oxford University suspends AstraZeneca vaccine trial on children
Oxford University has paused a trial of the vaccine on children and teenagers until further review by the British regulator.
UK regulator says AstraZeneca vaccine safe despite 7 clot deaths
UK medicines agency confirms seven deaths from rare blood clots from 18m people who received the AstraZeneca vaccine but says benefits still far outweigh risks.
Dutch suspend AstraZeneca jab for under-60s over blood clot fears
The Netherlands has temporarily halted the use of the AstraZeneca COVID-19 vaccine for people aged under 60 as a “precaution” after fresh concerns about blood clots were raised by an advisory body.
Did Scandinavia overreact in suspending AstraZeneca vaccinations?
Even as the EU regulator says the benefits outweigh the risks, Scandinavian countries remain wary of AstraZeneca's vaccine.
Germany suspends use of AstraZeneca COVID vaccine for under-60s
Germany has paused the use of the AstraZeneca COVID-19 vaccine for people under the age of 60 following concerns about rare blood clots.
Kosovo receives first COVID-19 vaccines through Covax scheme
Kosovo said they had received 24,000 AstraZeneca vaccines, which will be used for medical personnel, elderly people and those with chronic diseases.
Vaccine hesitancy 'rises in France' after AstraZeneca suspension
Vaccine hesitancy has risen sharply in France since countries across Europe suspended the AstraZeneca jab amid reports it causes blood clots.